Liver transplant study seeks better way to predict patient survival
NCT ID NCT07570901
First seen May 14, 2026 · Last updated May 25, 2026 · Updated 3 times
Summary
This study looked at 446 adults who received their first liver transplant to see if changes in their MELD score (a measure of liver disease severity) could predict survival. The goal was to find factors that affect outcomes, especially for patients with very severe liver disease. The study did not test a new treatment but aimed to improve how doctors assess risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jena University Hospital
Jena, Thueringia, 07747, Germany
-
Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
Conditions
Explore the condition pages connected to this study.